ADDITIVE BENEFITS of KALTENBORN SUSTAINED STRETCH JOINT MOBILIZATION with RESISTANCE EXERCISE TRAINING in KNEE OSTEOARTHRITIS

October 1, 2024 updated by: Foundation University Islamabad
to determine the supplementary effects of Kaltenborn sustained stretch mobilization when combined with resistance training in the management of knee osteoarthritis.

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Pakistan
    • Federal
      • Islamabad, Federal, Pakistan, 66000
        • Foundation University Islamabad

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Grade I-III knee OA Both male and female nee osteoarthritis for at least 3 months knee pain no more than 8/10

Exclusion Criteria:

Malignancy Any additional Inflammatory disorders Infection Knee trauma lower limb fracture Lumbar radiculopathy or myelopathy knee surgery Intra-articular steroid therapy in the last 2 months Total knee replacement (TKR). Total hip replacement (THR). Any neurological disorder Any cardio-pulmonary complications Rheumatoid arthritis Septic arthritis Recent history of trauma Osteoporosis or osteomyelitis Grade IV osteoarthritis

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Resistance Exercise
Procedure: Resistance Exercise Training
Resistance Exercise Training for knee
Experimental: Resistance exercise + joint mobilization
Procedure: Resistance Exercise Training
Resistance Exercise Training for knee
Procedure: Joint Mobilization
Tibiofemoral and Patellofemoral Joint Mobilization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knee Pain
Time Frame: 4 weeks
Knee Pain will be quantified using Numeric Pain Rating Scale (NPRS). NPRS is a 11 point scale form 0-10. Lower Score on NPRS signifies less pain, whereas higher score on NPRS signifies more pain.
4 weeks
Physical Function
Time Frame: 4 weeks
To determine the physical function related to knee osteoarthritis Western Ontario and McMaster Universities Arthritis Index (WOMAC) will be used with a total of 24 items and a higher score on WOMAC signifies poor outcome.
4 weeks
Isometric Muscle Strength
Time Frame: 4 weeks
Modified Sphygmomanometer will be used to measure isometric muscle strength of the muscles of the knee joint. A higher score signifies greater strength.
4 weeks
Functional Mobility strength
Time Frame: 4 weeks
5 repetition sit to stand test will be used to determine functional mobility strength. Less time to complete the task signifies better outcome.
4 weeks
Cadence
Time Frame: 4 weeks
Observational gait analysis will be used to determine cadence. A higher score signifies better outcome.
4 weeks
Gait velocity
Time Frame: 4 weeks
Observational gait analysis will be used to determine cadence. A higher score signifies better outcome.
4 weeks
Stride length
Time Frame: 4 weeks
Observational gait analysis will be used to determine cadence. A higher score signifies better outcome.
4 weeks
Knee range of motion (ROM)
Time Frame: 4 weeks
Gonimeter will be used to measure knee range of motion.. A higher score signifies better outcome.
4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Foundation University Islamabad

Investigators

  • Principal Investigator: Anas Hameed, Foundation University Islamabad
  • Study Chair: Muhammad Osama, Foundation University Islamabad

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2024

Primary Completion (Estimated)

April 2, 2025

Study Completion (Estimated)

April 2, 2025

Study Registration Dates

First Submitted

January 8, 2024

First Submitted That Met QC Criteria

January 8, 2024

First Posted (Actual)

January 18, 2024

Study Record Updates

Last Update Posted (Actual)

October 3, 2024

Last Update Submitted That Met QC Criteria

October 1, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FUI/CTR/2023/22

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe